CL
CNMD icon

Choreo LLC’s CONMED CNMD Stock Holding History

Choreo LLC’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$527K Buy
16,091
+2,646
+20% +$95.3K 0.01% 963
2026
Q1 		$475K Buy
13,445
+3,324
+33% +$135K 0.01% 969
2025
Q4 		$416K Sell
10,121
-2,016
-17% -$87.7K 0.01% 1016
2025
Q3 		$573K Buy
12,137
+4,729
+64% +$245K 0.01% 864
2025
Q2 		$387K Buy
7,408
+900
+14% +$49.4K 0.01% 1036
2025
Q1 		$394K Sell
6,508
-158
-2% -$10.2K 0.01% 954
2024
Q4 		$461K Sell
6,666
-492
-7% -$34.3K 0.01% 947
2024
Q3 		$490K Buy
7,158
+1,209
+20% +$85.3K 0.01% 916
2024
Q2 		$399K Buy
+5,949
New +$434K 0.01% 930

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Choreo LLC's CNMD Position: Q2 2026 in Review

Choreo LLC increased its CONMED (CNMD) stake by 20% in Q2 2026, buying an estimated $95.3K and bringing the position to 16,091 shares worth $527K. The position accounts for 0.01% of the portfolio, ranked #963.

Choreo LLC first reported a position in CNMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $573K in Q3 2025. 247 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Choreo LLC held 16,091 shares of CONMED worth $527K as of Q2 2026.
  • Choreo LLC bought 2,646 CONMED shares in Q2 2026, an estimated $95.3K.
  • CONMED made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #963 holding.
  • Choreo LLC first reported a position in CONMED in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's CONMED position peaked at $573K in Q3 2025.
  • 247 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.